BIOMAT Database Logo BIOMAT Database Logo

Studies on the stability of factor VIII coagulant antigen (VIII:CAg) in the presence of VIII:C antibodies. 1983

R A Furlong, and I R Peake

The stability of factor VIII coagulant antigens (VIII:CAg) at 56 degrees C was investigated using an immunoradiometric assay for VIII:CAg. In normal or CRM+ haemophilic plasmas VIII:CAg was rapidly inactivated at 56 degrees C. VIII:CAg in spontaneous VIII:C inhibitor plasmas and in post-treatment samples from haemophiliacs with VIII:C inhibitor was resistant to inactivation at 56 degrees C, indicating the presence of heat stable VIII:CAg-anti VIII:CAg complexes. In vitro VIII:CAg-anti VIII:CAg complexes were formed by incubation of diluted VIII:C antibodies and normal plasma and the stability of these complexes at 56 degrees C was studied. Haemophilic VIII:CAg antibodies formed heat stable immune complexes over a narrow range of inhibitor dilutions whilst some spontaneous VIII:CAg antibodies formed these stable complexes over a much wider range of dilutions emphasizing the difference in the properties of these antibodies.

UI MeSH Term Description Entries
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor

Related Publications

R A Furlong, and I R Peake
Radioimmunoassay for coagulant factor VIII-related antigen (VIII:CAg).
January 1979, Thrombosis research,
R A Furlong, and I R Peake
Immunologic studies of factor VIII coagulant activity (VIII:C). 2. Factor VIII in selected vertebrates.
March 1982, Thrombosis research,
R A Furlong, and I R Peake
An enzyme immunoassay (ELISA) for the quantitation of human factor VIII coagulant antigen (VIII:CAg).
September 1983, Thrombosis research,
R A Furlong, and I R Peake
Immunologic studies of factor VIII coagulant activity (VIII:C) 1. Assays based on a haemophilic and an acquired antibody to VIII:C.
January 1981, Thrombosis research,
R A Furlong, and I R Peake
Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag.
August 1983, Thrombosis and haemostasis,
R A Furlong, and I R Peake
Effect of phospholipid on factor VIII coagulant activity and coagulant antigen.
June 1983, Thrombosis research,
R A Furlong, and I R Peake
The effects of plasmin and protein Ca on factor VIII:C and VIII:CAg.
July 1983, Thrombosis research,
R A Furlong, and I R Peake
Factor VIII coagulant antigen in factor IX complex concentrates.
January 1979, Thrombosis research,
R A Furlong, and I R Peake
Studies on the stability of VIII:C during the manufacture of a factor VIII concentrate for clinical use.
January 1988, Vox sanguinis,
R A Furlong, and I R Peake
Studies on a monoclonal antibody to human factor viii coagulant activity, with a description of a facile two-site factor VIII coagulant antigen assay.
May 1983, The Journal of laboratory and clinical medicine,
Copied contents to your clipboard!